Search
Chengdu HitGen Terminates Acquisition of 65% Stake in Nanjing Haina Pharmaceutical Technology
2 day ago /
Read about 0 minute
Author：小编
Chengdu HitGen had initially intended to acquire approximately 65% of the equity in Nanjing Haina Pharmaceutical Technology through a cash transaction. However, following thorough research and consultations, the company has decided to terminate this significant asset reorganization due to an inability to reach a consensus on key terms.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
